Fear of Recurrence and Stopping Immunotherapy
ConditionCognitive Behavioral Therapy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorUniversity of Pittsburgh
About this trial
The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.
Eligibility criteria
Qualifiers
Age 21 years and older
Fluent in English
Diagnosis of cancer and history of treatment with immunotherapy
Disqualifiers
Active suicidal ideation, delusions or hallucinations
Trial design
Treatments tested in this trial
- cognitive behavioral therapy
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov